Food and drug administration authorizes the very first at-residence examination for COVID-19 and the flu

  • Home
  • Health and Fitness
  • Food and drug administration authorizes the very first at-residence examination for COVID-19 and the flu

Today(today’s date), the US Food and Drug Administration has authorized the first at-home examination for coronavirus (COVID-19) and the flu. The Laboratory Designed Test, created by Ellume Health, is designed to detect both flu and COVID-19.

This new test offers individuals the ability to self-administer the exam while at home. The assessment is easy to use and takes just 15 minutes. It involves dipping a swab into the back of your nose and utilizes near-patient, portable technology.

This new authorization provides individuals, who may be reluctant or unable to visit testing locations, with another option to determine if they are sick. According to Stephen Hahn, M.D., commissioner of the FDA, “Today’s authorization of the first at-home diagnostic test for COVID-19 is a significant step in empowering individuals to take charge of their health.”

The test, which is currently only available with a doctor’s prescription, does does not require lab processing and is proven to be accurate in detecting both influenza type A and B, as well as COVID-19.

A recent survey conducted by Ellume Health indicated that approximately 28 percent of individuals would prefer to have a rapid, accurate, and validated home test kit to detect COVID-19 and the flu. With the authorization of this first diagnostics kit, individuals across the US can now easily and quickly test themselves.

This authorization of the first at-home test provides individuals with a convenient and accurate testing alternative, allowing them to stay informed of their health and treatment needs. This will also decrease the spread of both flu and COVID-19. What is more, this test could potentially help individuals make better-informed decisions about isolation, quarantine, and contact tracing, as well as help reduce healthcare costs associated with rapid testing.

Overall, this new at-home test is a welcome addition that allows individuals to easily, accurately, and quickly test themselves for both COVID-19 and the flu. [ad_1]

Lucira Health, which developed the dual-purposed diagnostic test, said it can provide a positive result as fast as 11 minutes and a negative result in about 30 minutes.

The at-house nasal swab package simultaneously exams for COVID-19 and two strains of the flu.

(Graphic credit rating: Lucira Well being)


Supply connection